BPA Call 19GE5021A0003-19GE5021F7011
Award Date 9/1/21
Potential Completion Date 8/31/22
Potential Value $27K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Thailand
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price contract was awarded to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq sequencing system. The $27,344.86 contract is a call against a previously awarded Blanket Purchase Agreement to support infectious disease monitoring and research conducted by U.S. government health agencies, including the Centers for Disease Control and Prevention (CDC), operating programs in Thailand. No set-aside was used for this award....
- This is a firm fixed price contract awarded by the Office of Intergovernmental and External Affairs, a civilian agency, to Bio-Active Company LIMITED, a for-profit limited liability company, to provide services on the Illumina MiSeq genetic sequencing system. The contract has a ceiling value of $27,212.02 and a period of performance through August 31, 2025. This is a call order issued against a previously established Blanket Purchase Agreement held by Bio-Active Company LIMITED to provide...
- This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Bio-Active Company LIMITED, a for-profit limited liability company, for the acquisition of lab reagents for whole genome sequencing with Illumina instruments on behalf of the CDC's Division of Global Health Protection (DGHP) in Thailand. The contract, valued at $81,470.59, has an ultimate completion date of October 31, 2024. Bio-Active Company LIMITED has a history of delivering genetic...
- This federal contract award is for "SERVICES ON MISEQ SYSTEM" to be provided by Bio-Active Company LIMITED, a for-profit limited liability company, to the Centers for Disease Control and Prevention (CDC) operating out of a facility in Thailand. The contract, valued at $26,438.95, is a firm fixed price Blanket Purchase Agreement (BPA) call, with a period of performance ending on August 31, 2023. The contract does not have a set-aside designation. Bio-Active Company LIMITED has...
- This is a $138,356.92 firm fixed price purchase order awarded by the Department of Health and Human Services to Bio-Active Company LIMITED, a for-profit limited liability company in Thailand. The contract is for a "NGS PLATFORM SEQUENCING SYSTEM" to support the Centers for Disease Control and Prevention's (CDC) infectious disease monitoring and research programs in Thailand. Bio-Active Company LIMITED has a history of providing genetic sequencing systems, reagents, and testing...
- This is a firm-fixed-price purchase order awarded by the Defense Health Agency, a component of the U.S. Department of Defense, to Bio-Active Company LIMITED, a for-profit limited liability company located in Thailand. The $112,739.29 contract is for the purchase of an Illumina MiSeq genetic sequencing system, including reagents and associated components. This award is not associated with a larger contract vehicle, and no small business set-aside provisions were used. Bio-Active Company LIMITED...
- This is a firm fixed price contract awarded by the Office of the Secretary of Defense to Bio-Active Company LIMITED, a for-profit limited liability company, to provide maintenance and emergency services for an Illumina MiSeq genetic sequencing instrument located in Thailand. The contract, valued at $29,088.00, is a call against a pre-existing Blanket Purchase Agreement to support infectious disease monitoring and research efforts by various U.S. government agencies, including the Centers for...
- This is a firm fixed-price purchase order awarded by the U.S. Department of the Army to Bio-Active Company LIMITED, a for-profit limited liability company based in Thailand. The contract is for the procurement of Illumina sequencing platforms, including MiSeq and NextSeq systems, to be used for DNA and RNA sequencing of clinical, environmental, and vector-borne disease samples. The award has a ceiling value of $223,391.17 and an ultimate completion date of September 7, 2026. Bio-Active Company...
- This is a firm fixed price contract awarded to Bio-Active Company LIMITED, a for-profit limited liability company, by the U.S. Department of Defense's Medical Command (MEDCOM). The contract provides for services related to the operation and maintenance of Illumina MiSeq genetic sequencing systems used to support infectious disease monitoring and research in Thailand. The award, valued at $27,615.93, is a call against a previously established Blanket Purchase Agreement between Bio-Active...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents, to provide six "Illumina MiSeq Kit v2 (500 Cycle) - 20 Pack" for $132,114.00. This contract does not have a set-aside designation. Illumina has previously provided sequencing instruments, reagents, and related services to federal agencies such as the NIH,...